Vertebralni osteomijelitis u odraslih bolesnika – karakteristike i ishod by Matej Mustapić et al.
Acta Clin Croat,  Vol. 55,   No. 1,  2016 9
Acta Clin Croat 2016; 55:9-15 Original Scientific Paper
doi: 10.20471/acc.2016.55.01.2
VERTEBRAL OSTEOMYELITIS IN ADULT PATIENTS – 
CHARACTERISTICS AND OUTCOME
Matej Mustapić1, Klaudija Višković2, Igor Borić3, Domagoj Marjan1, Dijana Zadravec1 
and Josip Begovac4
1Department of Diagnostic and Interventional Radiology, Sestre milosrdnice University Hospital Center; 
2Department of Radiology and Ultrasound, Dr Fran Mihaljević University Hospital for Infectious Dise-
ases, Zagreb; 3Department of Radiology, Sveta Katarina Special Hospital, Zabok; 4 Dr Fran Mihaljević 
University Hospital for Infectious Diseases, Zagreb, Croatia
SUMMARY – The aim of the study was to assess disease characteristics and outcome in patients 
with vertebral osteomyelitis (VO). A two medical centre retrospective cohort study was performed 
by chart review after discharge of 110 patients with confirmed VO treated during a 5-year period. 
Patients were divided in two groups: patients with uncomplicated VO and patients with compli-
cated VO. All patients underwent clinical and biological examinations and magnetic resonance 
imaging (MRI) according to the same protocol. Patients with complicated VO were significantly 
older (p=0.038). They were longer treated with antibiotics parenterally (p=0.047) and more often 
surgically (p<0.001). In these patients, high Charlson comorbidity index (CCI) score was more often 
observed (p=0.024), as well as liver cirrhosis (p=0.013) and degenerative spine disease (p=0.007) as 
comorbidities. Patients with advanced MRI changes of VO had a modified CCI score of 2 or more 
(p=0.006). They more often experienced neurological deficit (p=0.021). Staphylococcus aureus was 
the most frequently isolated bacterium from blood and tissue samples. Advanced MRI changes and 
complicated VO were more often observed in patients with high CCI score due to impaired immune 
system caused by chronic comorbid disease(s) or modulation of immunity with medications. High 
CCI scores were more frequently associated with positive blood cultures due to bacteremia because 
of impaired immunity. Patients with complicated VO were longer treated with antibiotics paren-
terally and more often surgically treated for phlegmon and abscess formation. Liver cirrhosis and 
degenerative spine disease, which were more often found in patients with complicated VO, obviously 
impacted the course of the disease.
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Introduction
Vertebral osteomyelitis (VO) accounts for 2%-4% 
of bone and joint infections1. The incidence of VO 
seems to be increasing because of higher life expec-
tancy in older patients with serious comorbidities and 
increase of spinal surgery, as well as other invasive 
procedures resulting in bacteremia. The most frequent 
comorbidities in these patients are diabetes mellitus, 
immunodeficiencies and malignancies2,3. Pain is the 
commonest symptom of early VO while fever may 
not be present (frequency varies from 35% to 60%)4. 
Neurological symptoms, such as numbness, weak-
ness or radiculopathy, are present in about one-third 
of patients5. The most common bacterial pathogen is 
Staphylococcus aureus with an incidence between 30% 
and 80%6. Mortality is attributable in part to comor-
bidities and ranges from 2% to 30%1,7.
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Magnetic resonance imaging (MRI) is by far the 
most valuable imaging procedure for early diagnosis 
and follow-up of patients with osteomyelitis includ-
ing VO7-9. MRI with a paramagnetic contrast me-
dium and fat suppression techniques shows sensitivity 
similar to scintigraphy (96%) and specificity equal to 
computed tomography (CT) (93%)10. The Charlson 
comorbidity index (CCI) is a method of predicting 
mortality by classifying or weighting comorbid con-
ditions11. To measure disease burden, Charlson et al. 
assigned a weighted score to each comorbid condition 
based on the relative risk of 1-year mortality11. Among 
many potential comorbidity variables assessed, 17 were 
found to be associated with 1-year mortality. Quan 
et al. updated the CCI based on the hazard ratios of 
individual comorbidities for mortality within 1 year 
after hospital admission12. 
The aim of this study was to assess disease charac-
teristics and outcome in patients with VO. There are 
no specific studies in which MRI findings and CCI 
score were observed in patients with VO.
Materials and Methods
Study design
A two-centre, retrospective analysis included con-
secutive adult (≥18 years of age) patients treated for 
definite VO between January 1, 2006 and December 
31, 2011 at Dr Fran Mihaljević University Hospital 
for Infectious Diseases and Sestre milosrdnice Uni-
versity Hospital Center in Zagreb. During this pe-
riod, all patients suspected of having VO underwent 
the same standardized in-house protocol with detailed 
prospective data recording. 
For the purpose of the study, the hospital elec-
tronic database and source data were searched inde-
pendently by two investigators to identify qualifying 
patients and to double-check the extracted data. All 
the patients had MRI of the spine and all the images 
were reviewed by two senior musculoskeletal radiolo-
gists who were blind to clinical data. The study was 
approved by the institutions’ Ethics Committees.
Patients
Vertebral osteomyelitis was diagnosed based on 
clinical presentation (unremitting back or neck pain, 
presence of fever ≥38.1 °C, and neurological deficits) 
and supportive MRI findings (we observed: initial 
MRI findings – vertebral body edema and discitis; 
and advanced MRI findings – height reduction of the 
intervertebral disc, vertebral body endplate erosions, 
compression fracture and intraosseous, paravertebral 
or epidural abscesses). 
Out of the total of 239 adults with VO treated 
during the observed period, the present analysis em-
braced 110 patients (54.5% males and 45.5% females). 
Exclusions were due to MRI examination performed 
by different protocols, and vertebral lesions due to pri-
mary or secondary bone tumors and proved tubercu-
lous, parasitic or fungal etiology.
Magnetic resonance imaging 
Magnetic resonance imaging was done using a 
Siemens Avanto 1.5 T scanner (Siemens, Erlangen, 
Germany) performing routine imaging techniques in-
cluding contrast-enhanced T1-weighted images (WI) 
in axial, coronal and sagittal plane. A paramagnetic 
contrast agent gadopentetate dimeglumine (Magnev-
ist, Schering, Berlin, Germany) was used in a dose of 
0.1 mmol/kg. 
Treatment 
Initial empirical antibiotic treatment recommend-
ed by the Hospital Drugs Committee was followed 
by, when applicable, a bacteriologically targeted treat-
ment in overall duration of six to eight weeks. In a 
significant proportion of patients, surgical interven-
tion was needed because of complications (formation 
of abscesses, bone destruction and spine instability 
compromising neural structures). 
Comorbidities
Underlying medical conditions (comorbidities) 
were scored through the modified CCI and stratified 
in two groups according to the CCI score: low (0-1) 
or high (≥2)2,12,13. Serious comorbidity includes im-
munodeficiency (due to immunosuppressants, HIV 
infection or splenectomy, diabetes mellitus and ma-
lignancy), major rheumatic inflammatory diseases of 
the spine (rheumatoid arthritis, psoriatic arthritis and 
ankylosing spondylitis), degenerative spine diseases 
and other chronic organ diseases (alcohol abuse or cir-
rhosis, endocrine disease except for diabetes mellitus, 
and chronic heart, lung, kidney or liver disease). 
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Disease outcome
We divided patients into two groups: patients 
with uncomplicated VO and patients with compli-
cated VO. Complicated VO implies the following: 1) 
need for surgical intervention; 2) incomplete recovery 
with residual motor weakness or paralysis or pain that 
limits activity after completion of antimicrobial treat-
ment; 3) interruption of antibiotic therapy before three 
months of duration on patient’s demand with residual 
motor weakness or paralysis or pain that limits activ-
ity; and 4) death.
Data analysis 
Data were summarized for the entire cohort and 
also separately for the patients with uncomplicated 
VO and complicated VO. We computed frequen-
cies for categorical variables and medians and in-
terquartile ranges (IQR) for non-
normally distributed continuous 
variables. To compare different char-
acteristics of patients with low and 
those with high CCI score, we used 
Whitney-Mann test for continuous 
variables and Fisher’s exact test or 
χ2-test for categorical variables. All 
statistical tests were two-tailed, and 
a p value of <0.05 was considered to 
be statistically significant. Statistical 
analyses were performed using the 
Statistical Product and Service 
Solutions (SPSS) software version 13 
(SPSS Inc., Chicago, IL, USA).
Results
Patient and disease characteristics
A total of 239 patients with VO 
were identified during the study 
period and 110 patients were included 
in the study. The median patient age 
was 59.5 years. Most patients expe-
rienced pain and had fever, and one-
third of patients had neurological 
complications (92%, 59% and 36%, re-
spectively). Patients with complicated 
VO were significantly older (median 
age 62.5 vs. 55.0 years, p=0.038) and 
more often experienced neurological deficit (p=0.021). 
Spinal infection was most frequently located in the 
lumbar spine (64% of patients). There was no differ-
ence between patients with uncomplicated VO and 
complicated VO according to gender, time from symp-
tom onset to hospital admission and MRI established 
diagnosis, erythrocyte sedimentation rate (ESR) and 
C-reactive protein (CRP) values, duration of hospi-
talization, anatomic site of infection and number of 
vertebral bodies affected. Demographic and clinical 
data of study patients are presented in Table 1.  
Comorbidities
Sixty-three (57.3%) patients had one or more co-
morbidities. Thirty-seven (33.6%) patients had a high 
modified CCI score of 2 or more. There was a statisti-
cally significant difference in the frequency of comor-
bidities between patients with uncomplicated VO and 










Age (yrs) 55.0 (47.0, 66.0)* 62.5 (53.0, 70.0)* 0.038














hospitalization 34.0 (27.0, 53.0)*
42.5 (29.5, 
59.0)* 0.1

















8.5 (6.0, 10.0)*      
32.5 (22.0, 42.0)*  





*median (Q1, Q3); VO = vertebral osteomyelitis; MRI = magnetic resonance imaging; 
ESR = erythrocyte sedimentation rate; CRP = C-reactive protein 
12 Acta Clin Croat,  Vol. 55,   No. 1,  2016
M. Mustapić et al. Vertebral osteomyelitis
complicated VO according to liver cirrhosis and degen-
erative spine disease. The frequency of comorbidities 
detected in patients with VO is shown in Table 2.
Etiology
The etiology in VO was proved in 67 patients 
(67/110; 61.0%). Forty-three patients had posi-
tive blood cultures (43/97; 39.0%) and 24 patients 
had positive tissue cultures (24/33; 22.0%). In both 
groups of patients, Staphylococcus aureus was the most 
frequently isolated bacterium from blood (52.0% in 
uncomplicated VO and 47.0% in complicated VO) 
and tissue (78.0% and 55.0%, respectively) sample 
cultures. Patients with positive blood culture had a 
significantly higher mean ESR (78.1 vs. 63.2 mm/h, 
p=0.024) and CRP (178.8 vs. 90.9 mg/L, p<0.001), 
higher fever (p<0.001) and most commonly high CCI 
score (p=0.019).
Magnetic resonance imaging
The time of radiological diagnosis of VO from the 
onset of symptoms ranged from 2 to 90 days, median 
15 days (IQR:10-30). Vertebral edema was detect-
ed in 108 (98.2%), discitis in 92 (83.6%), decreased 
disc height in 29 (26.4%), vertebral destruction in 53 
(48.2%) and abscesses in 67 (60.9%) patients. There 
were 81 patients with advanced (Figs. 1 and 2) and 19 
patients with initial (Fig. 3) MRI findings. Patients 




Degenerative spine disease 6 (13.0%) 23 (36.0%) 0.007
Diabetes mellitus 5 (11.0%) 14 (22.0%) 0.13
Rheumatic inflammatory disease 5 (11.0%) 7 (11.0%) 0.99
Cardiovascular disease 3 (7.0%) 7 (11.0%) 0.43
Liver cirrhosis 0 (0.0%) 8 (13.0%) 0.013
Chronic renal failure 3 (7.0%) 7 (11.0%) 0.2
Malignancy 1 (2.0%) 4 (6.0%) 0.31
Alcohol abuse 0 (0.0%) 3 (5.0%) 0.14
Fig. 1. Sagittal T1WI shows dif-
fuse edema of L4 and L5 verte-
bral bodies, decreased disc height, 
and hypointensity of prevertebral 
and epidural fat due to inflam-
mation.
Fig. 2. Contrast-enhanced sagittal T1WI re-
veals bone marrow hyperemia of L4 and L5 
vertebral bodies, peripheral rim enhancement of 
intervening disc due to abscess formation with 
endplate erosions, and prevertebral and epidural 
phlegmon.
Fig. 3. Sagittal T1WI shows 
diffuse hypointensity of L5 ver-
tebral body due to edema. Disc 
height at L4-L5 and L5-S1 is 
preserved.
1 2 3
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with advanced MRI changes of VO had a modified 
CCI score of 2 or more (p=0.006).
Disease outcome
There were 64 patients with complicated VO out 
of 110 patients included in the study. They were longer 
treated with antibiotics parenterally (median days 37.0 
vs. 32.5; p=0.047) and more often surgically (p<0.001). 
In these patients, high CCI score was more often ob-
served (p=0.024), as well as liver cirrhosis (p=0.013) 
and degenerative spine disease (p=0.007) as comor-
bidities. Twenty-four (21.8%) patients had residual 
neurological deficits or pain; ten of them were treated 
for less than 8 weeks because therapy was aborted on 
their demand. Nine (8.2%) patients died before the 
end of treatment. 
Discussion
In our study, about one-third of patients with VO 
were found to have high CCI score. These patients had 
a significantly higher incidence of advanced changes 
in MRI findings and more often had complicated VO, 
compared with patients with low CCI score, probably 
due to impaired immune response caused by diabetes 
or chronic renal failure or because of partial modula-
tion of immune response with medications in patients 
with inflammatory rheumatic diseases. The altered 
immune system obviously had an impact on the se-
vere disease course in these patients. They had a high-
er incidence of neurological deficits due to epidural 
phlegmon and abscess formation according to MRI 
findings, and consequently the need for surgical treat-
ment and prolonged antimicrobial therapy. Except for 
degenerative spine disease, the distribution of comor-
bidities in patients in our study was similar to study 
results described by Bhavan et al. and Carragee14,15. 
They report on diabetes and chronic renal failure as 
the leading comorbidities in patients with VO, but did 
not observe degenerative spine disease as a comorbid-
ity in their patients. 
More frequently observed higher values of ESR 
and CRP, and higher fever in patients with positive 
blood culture were due to bacteremia in these pa-
tients, which led to a more pronounced inflammatory 
response of the body. Patients with positive blood 
culture had most commonly high CCI score, which 
caused bacteremia due to impaired immune system.
Patients with complicated VO more often experi-
enced neurological deficit, but there was no significant 
difference according to gender, time from symptom 
onset to hospital admission and MRI established 
diagnosis, duration of hospitalization, anatomic site 
of infection and number of affected vertebral bodies 
between patients with uncomplicated VO and com-
plicated VO. Generally, most patients were older 
men, experienced pain and had fever, and one-third 
of patients had neurological complications, confirm-
ing previous findings14,16,17. Spinal infection was most 
frequently located in the lumbar spine and usually 
affected two neighboring vertebrae and intervening 
disc, which is similar to other previously conducted 
studies2,5. 
The median interval between the onset of symp-
toms and MRI examination was similar to the results 
of Carragee, who reports that MRI scans were ob-
tained within less than 3 weeks after symptom on-
set15. The most commonly identified microorganism 
was S. aureus, both in blood cultures and percutaneous 
bone biopsy cultures, which is consistent with the re-
sults reported by Mylona et al., Chen et al., Beronius 
et al. and Legrand et al.3,18-20. There was no difference 
in total duration of therapy, but patients with compli-
cated VO were longer treated parenterally and more 
often surgically for epidural phlegmon and abscess 
formation. 
Our study has several limitations, i.e. retrospective 
design, lack of follow-up MRI and follow-up mea-
surements of laboratory parameters such as ESR and 
CRP. Routine use of follow-up MRI in patients who 
have clinical response to therapy is not supported by 
Kowalski et al.21. We agree with Dunbar et al. that 
follow-up MRI 2-3 weeks after initial MRI seems 
reasonable in cases where there is clinical evidence 
for spinal infection but the initial MRI is negative or 
inconclusive22. Instead of follow-up MRI, follow-up 
measurements of ESR and CRP may be useful to de-
termine the response to antibiotic or surgical treat-
ment. 
Conclusion
Advanced MRI changes and complicated VO were 
more often observed in patients with high CCI score, 
probably due to impaired immune system caused by 
chronic comorbid disease(s) or modulation of immune 
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response with medications. High CCI scores were 
more frequently associated with positive blood cul-
tures due to bacteremia because of impaired immune 
system. Patients with complicated VO were older, 
longer treated with antibiotics parenterally and more 
often surgically treated. Liver cirrhosis and degenera-
tive spine disease, which were more often found in 
patients with complicated VO, obviously impacted 
the course of the disease.
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Sažetak
VERTEBRALNI OSTEOMIJELITIS U ODRASLIH BOLESNIKA – KARAKTERISTIKE I ISHOD
M. Mustapić, K. Višković, I. Borić, D. Marjan, D. Zadravec i J. Begovac
Ciljevi istraživanja su bili prikazati karakteristike i ishod vertebralnog osteomijelitisa (VO) u odraslih bolesnika. Radi 
se o retrospektivnoj studiji u koju je bilo uključeno 110 bolesnika s VO koji su hospitalizirani u petogodišnjem razdoblju. 
Bolesnici su podijeljeni u skupinu s nekompliciranim i skupinu s kompliciranim VO. Svi bolesnici su imali nalaze labora-
torijskih pretraga i MR pregled kralježnice. Bolesnici s kompliciranim VO su bili značajno stariji (p=0,038), duže su pa-
renteralno liječeni antibioticima (p=0,047) i češće su kirurški liječeni (p<0,001). U istih bolesnika su češće bili zastupljeni 
viši stupanj komorbiditeta po Charlsonu (engl. Charlson comorbidity index score, CCI score) (p=0,024), ciroza jetre (p=0,013) 
i degenerativna bolest kralježnice (p=0,007) za razliku od bolesnika s nekompliciranim VO. Bolesnici s uznapredovalim 
MR promjenama su češće imali viši zbir CCI, 2 ili više (p=0,006) te učestalije neurološke ispade (p=0,021). Staphylococcus 
aureus je najčešće izolirana bakterija iz krvi i tkiva. Uznapredovale MR promjene i komplicirani VO su češće bili zastuplje-
ni u bolesnika koji su imali viši zbir CCI, najvjerojatnije zbog oštećenja imunog sustava uslijed komorbiditeta ili promjene 
imunog odgovora lijekovima. Viši zbir CCI je češće bio udružen s pozitivnim hemokulturama uslijed bakterijemije zbog 
oštećenja imuniteta. Bolesnici s kompliciranim VO su duže parenteralno liječeni antibioticima zbog učestalijih flegmona 
ili apscesa. Ciroza jetre i degenerativna bolest kralježnice koji su kao komorbiditeti bili učestaliji u bolesnika s komplicira-
nim VO najvjerojatnije su utjecali na tijek bolesti.
Ključne riječi: Osteomijelitis kralježnice; Magnetska  rezonancija, snimanje; Komorbiditet; Ishod zdravstvene skrbi, ocjena; 
Odrasla osoba
